Search

everythinglearnresearchcommunity

for

Search:↓

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

The girl's hair loss is due to trichotillomania, which may improve with behavioral therapy or a combination of treatments.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Type 3 acromegaly patients have more health issues and higher death risk.

Obesity significantly affects skin health, causing conditions like acanthosis nigricans and skin tags, and should be considered during skin exams.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

Addressing anxiety and mood disorders is crucial to reduce medication overuse in chronic migraine patients.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

The book explains causes and treatments for common hair loss, its psychological effects, related health risks, and emphasizes early screening and lifestyle changes.

Women know more about androgenetic alopecia than men.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Long COVID can cause long-lasting symptoms, but vaccination and early treatment can help prevent it.

People with polycystic ovary syndrome often experience anxiety and depression.

Lipedematous scalp may have a genetic link and could be associated with psychiatric conditions.

Ethnic Indian women with PCOS face significant care gaps, needing better support and information.

Many COVID-19 patients, especially women, experienced hair loss, often linked to diabetes and lack of dietary supplements.

The book provides comprehensive treatment strategies for female hair loss.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.